Loose Leaf for Drugs in American Society

(3)
Loose Leaf for Drugs in American Society image
ISBN-10:

1265671397

ISBN-13:

9781265671396

Author(s): Goode, Erich
Edition: 11
Released: Feb 01, 2022
Publisher: McGraw-Hill.
Format: Loose Leaf, 528 pages

Description:

Drugs in American Society provides a holistic introduction to drug use in the United States. This sociological introduction to the use of psychoactive substances takes a big-picture look at patterns of drug consumption in America while also focusing on the effects that drugs have on users' lives. This edition presents the most current research, data, and statistics on drug use and discusses the latest trends involving drugs, from the decriminalization and mainstreaming of marijuana to the opioid epidemic that has led to a startling rise in overdose deaths. Personal accounts of Americans who have taken drugs show the reality of drug use and provide insights that go beyond the portrayal of drugs in society and the news media.

Best prices to buy, sell, or rent ISBN 9781265671396




Related Books

Frequently Asked Questions about Loose Leaf for Drugs in American Society

You can buy the Loose Leaf for Drugs in American Society book at one of 20+ online bookstores with BookScouter, the website that helps find the best deal across the web. Currently, the best offer comes from and is $ for the .

The price for the book starts from $90.84 on Amazon and is available from 10 sellers at the moment.

If you’re interested in selling back the Loose Leaf for Drugs in American Society book, you can always look up BookScouter for the best deal. BookScouter checks 30+ buyback vendors with a single search and gives you actual information on buyback pricing instantly.

As for the Loose Leaf for Drugs in American Society book, the best buyback offer comes from and is $ for the book in good condition.

Loose Leaf for Drugs in American Society book is in low demand now as the rank for the book is 310,801 at the moment. It's a low rank, and the book has not much sales on Amazon.

Not enough insights yet.